Anti-sclerotic effect of transforming growth factor-β antibody in a mouse model of bleomycin-induced scleroderma

Clinical Immunology

Volumn 92, Issue 1, 1999, Pages 6-13

  Yamamoto, Toshiyuki ^a   Takagawa, Sinsuke ^a   Katayama, Ichiro ^a,b   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Animal model; Bleomycin; Scleroderma; TGF

Indexed keywords

BLEOMYCIN; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCLERODERMA;

EID: 0033017344     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4720     Document Type: Article

References (40)

1. Krieg T., Meurer M. Systemic scleroderma. J. Am. Acad. Dermatol. 18:1988;457-481.
2. LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A. Jr., Rowell N., Wollheim F. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J. Rheumatol. 15:1988;202-205.
3. Fleischmajer R., Perlish J. S., Reeves J. R. T. Cellular infiltrates in scleroderma skin. Arthritis Rheum. 20:1977;975-984.
4. Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield L. M., Heine U. I., Liotta L. A., Falanga V. A., Kehrl J. H., Fauci A. S. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA. 83:1986;4167-4171.
5. Sporn M. B., Roberts A. B. Transforming growth factor-β: Recent progress and new challenge. J. Cell Biol. 119:1992;1017-1021.
6. Ignotz R. A., Massague J. Transforming growth factor beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:1986;4337-4342.
7. Varga J., Rosenbloom J., Jimenez S. A. Transforming growth factor-β (TGF-β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem. J. 247:1987;597-604.
8. Raghu G., Masta G., Meyers D., Narayanan A. S. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-β Am. Rev. Respir. Dis. 140:1989;95-100.
9. Adamson I. V. R. Drug-induced pulmonary fibrosis. Environ. Health Perspect. 55:1984;25-36.
10. Aso Y., Yoneda K., Kikkawa Y. Morphological and biological study of pulmonary changes induced by bleomycin in mice. Lab. Invest. 35:1976;558-568.
11. Chandler D. B. Possible mechanisms of bleomycin-induced fibrosis. Clin. Chest Med. 11:1990;21-30.
12. Khalil N., Bereznay O., Sporn M., Greenberg A. H. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:1989;727-737.
13. Khalil N., O'Connor R. N., Unuh H. W., Warren P. W., Flanders K. C., Kemp A., Bereznay O. M., Greenberg A. H. Increased production and immunochemical localization of transforming growth factor beta in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:1991;155-162.
14. Broekelmann T. J., Limper A. H., Colby T. V., McDonald J. A. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonar fibrosis. Proc. Natl. Acad. Sci. USA. 88:1991;6642-6646.
15. Hoyt D. G., Lazo J. S. Alterations in pulmonary mRNA encoding procollagen, fibronectin and transforming growth factor-β precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246:1988;765-770.
16. Raghow R., Irish P., Kang A. H. Coordinate regulation of transforming growth factor β gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 84:1989;1836-1842.
17. Phan S. H., Kunkel S. L. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18:1992;29-43.
18. Yamamoto, T, Takagawa, S, Katayama, I, Yamazaki, K, Hamazaki, Y, Shinkai, H, and, Nishioka, K, Animal model of sclerotic skin. I. Local injections of bleomycin induce sclerotic skin mimicking scleroderma, J. Invest. Dermatol, in press.
19. Nishioka K., Kobayashi Y., Katayama I., Takijiri C. Mast cell numbers in diffuse scleroderma. Arch. Dermatol. 123:1987;205-208.
20. Needleman B. W., Wigley F. M., Stair R. W. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon-γ levels in sera from patients with scleroderma. Arthritis Rheum. 35:1992;67-72.
21. Woessener J. F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem. Biophys. 93:1961;440-447.
22. Border W. A., Noble N. A. Targeting TGF-β for treatment of disease. Nat. Med. 1:1995;1000-1001.
23. Grande J. P. Role of transforming growth factor-β in tissue injury and repair. Proc. Soc. Exp. Biol. Med. 214:1997;27-40.
24. Shah M., Foreman D. M., Ferguson M. W. J. Control of scarring in adult wounds by neutralising antibody to transforming growth factor β Lancet. 339:1992;213-214.
25. Giri S. N., Hyde D. M., Hollinger M. A. Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice. Thorax. 48:1993;959-966.
26. Denis M. Neutralization of transforming growth factor-β 1 in a mouse model of immune-induced lung fibrosis. Immunology. 82:1994;584-590.
27. Shenkar R., Coulson W. F., Abraham E. Anti-transforming growth factor-β monoclonal antibodies prevent lung injury in hemorrhaged mice. Am. J. Respir. Cell Mol. Biol. 11:1994;351-357.
28. Coker R. K., Laurent G. J., Shahzeidi S., Lympany P. A., du Bois R. M., Jeffery P. K., McAnulty R. J. Transforming growth factors-β1, -β2, and -β3 stimulates fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am. J. Pathol. 150:1997;981-991.
29. Kulozik M., Hogg A., Lankat-Buttgereit B., Krieg T. Co-localization of transforming growth factor β2 with α 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J. Clin. Invest. 86:1990;917-922.
30. Shah M., Foreman D. M., Ferguson M. W. J. Neutralisation of TGF-β 1 and TGF-β 2 or exogenous addition of TGF-3 to cutaneous rat wound reduces scarring. J. Cell Sci. 108:1995;985-1002.
31. Roberts A. B. Transforming growth factor-β: Activity and efficacy in animal models of wound healing. Wound Rep. Reg. 3:1995;408-418.
32. Clark J. C., Starcher B. C., Uitto J. Bleomycin-induced synthesis of type I procollagen by human lung and skin fibroblasts in culture. Biochim. Biophys. Acta. 631:1980;359-370.
33. Fernandez-Obregon A. C., Hogan K. P., Bibro M. K. Flagellate pigmentation for intrapleural bleomycin. J. Am. Acad. Dermatol. 13:1985;464-468.
34. Galli S. J. New concepts about the mast cell. N. Engl. J. Med. 328:1993;257-275.
35. Zhang K., Gharaee-Kermani M., Jones M. L., Warren J. S., Phan S. H. Monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J. Immunol. 153:1994;4733-4741.
36. Zhang K., Flanders K. C., Phan S. H. Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147:1995;352-361.
37. Pincus S. H., Ramesh K. S., Wyler D. J. Eosinophils stimulate fibroblast DNA synthesis. Blood. 70:1987;572-574.
38. Rochester C. L., Ackerman S. J., Zheng T., Elias J. A. Eosinophil-fibroblast interactions. J. Immunol. 156:1996;4449-4456.
39. Piguet P. F., Collart M. A., Grau G. E., Kapanci Y., Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:1989;655-663.
40. Zhang K., Gharaee-Kermani M., McGarry B., Remick D., Phan S. H. TNF-α-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J. Immunol. 158:1997;954-959.